Krystal Biotech (KRYS) Operating Income Growth (1y) (2017 - 2026)
Krystal Biotech (KRYS) Operating Income Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | 48.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.10% |
| Dec 31, 2025 | 7.00% |
| Sep 30, 2025 | 84.11% |
| Jun 30, 2025 | 358.87% |
| Mar 31, 2025 | 642.37% |
| Dec 31, 2024 | 1,173.86% |
| Sep 30, 2024 | 186.45% |
| Jun 30, 2024 | 122.51% |
| Mar 31, 2024 | 86.31% |
| Dec 31, 2023 | 109.34% |
| Sep 30, 2023 | 17.35% |
| Jun 30, 2023 | -32.33% |
| Mar 31, 2023 | 2.79% |
| Dec 31, 2022 | -58.95% |
| Sep 30, 2022 | -100.94% |
| Jun 30, 2022 | -75.40% |
| Mar 31, 2022 | -249.91% |
| Dec 31, 2021 | -109.94% |
| Sep 30, 2021 | -61.69% |
| Jun 30, 2021 | -135.73% |